| pubmed-article:10340041 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10340041 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:10340041 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:10340041 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
| pubmed-article:10340041 | lifeskim:mentions | umls-concept:C0349530 | lld:lifeskim |
| pubmed-article:10340041 | lifeskim:mentions | umls-concept:C0030191 | lld:lifeskim |
| pubmed-article:10340041 | lifeskim:mentions | umls-concept:C0032145 | lld:lifeskim |
| pubmed-article:10340041 | lifeskim:mentions | umls-concept:C0080055 | lld:lifeskim |
| pubmed-article:10340041 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:10340041 | lifeskim:mentions | umls-concept:C1441616 | lld:lifeskim |
| pubmed-article:10340041 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:10340041 | lifeskim:mentions | umls-concept:C0439611 | lld:lifeskim |
| pubmed-article:10340041 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10340041 | pubmed:dateCreated | 1999-6-1 | lld:pubmed |
| pubmed-article:10340041 | pubmed:abstractText | High levels of urokinase-type plasminogen activator (u-PA) were demonstrated in gastric carcinomas along with inhibitors of plasminogen activators (PAI-1 and PAI-2). They may influence the ability to invade and metastasize and therefore be of importance to the risk of recurrence of stomach neoplasms after curative operation. This also appears to be the case for p53 mutations and p53 protein overexpression. | lld:pubmed |
| pubmed-article:10340041 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10340041 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10340041 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10340041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10340041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10340041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10340041 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10340041 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:10340041 | pubmed:issn | 0368-2811 | lld:pubmed |
| pubmed-article:10340041 | pubmed:author | pubmed-author:HashimotoHH | lld:pubmed |
| pubmed-article:10340041 | pubmed:author | pubmed-author:KobayashiKK | lld:pubmed |
| pubmed-article:10340041 | pubmed:author | pubmed-author:EndoHH | lld:pubmed |
| pubmed-article:10340041 | pubmed:author | pubmed-author:KaminishiMM | lld:pubmed |
| pubmed-article:10340041 | pubmed:author | pubmed-author:TakuboKK | lld:pubmed |
| pubmed-article:10340041 | pubmed:author | pubmed-author:OoharaTT | lld:pubmed |
| pubmed-article:10340041 | pubmed:author | pubmed-author:KammoriMM | lld:pubmed |
| pubmed-article:10340041 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10340041 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:10340041 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10340041 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10340041 | pubmed:pagination | 187-91 | lld:pubmed |
| pubmed-article:10340041 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:meshHeading | pubmed-meshheading:10340041... | lld:pubmed |
| pubmed-article:10340041 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10340041 | pubmed:articleTitle | Immunohistochemical analysis of PAI-2 (plasminogen activator inhibitor type 2) and p53 protein in early gastric cancer patients with recurrence: a preliminary report. | lld:pubmed |
| pubmed-article:10340041 | pubmed:affiliation | Department of Surgery, University of Tokyo Branch Hospital, Japan. kammori-dis@h.u-tokyo.ac.jp | lld:pubmed |
| pubmed-article:10340041 | pubmed:publicationType | Journal Article | lld:pubmed |
